Glycosylation defining cancer cell motility and invasiveness

Published in 2004.

[1]  S. Hakomori,et al.  Glycoconjugate expression during embryogenesis and its biological significance , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  M. Seno,et al.  Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility , 1991, The Journal of experimental medicine.

[3]  H Kaltner,et al.  Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3* , 2001, The Journal of Biological Chemistry.

[4]  S. Hanash,et al.  The Major CD9 and CD81 Molecular Partner , 2001, The Journal of Biological Chemistry.

[5]  D. Kingsley,et al.  Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant , 1986, Cell.

[6]  S. Hakomori Carbohydrate-carbohydrate interaction as an initial step in cell recognition , 1991 .

[7]  K. Handa,et al.  Glycosphingolipid‐dependent cross‐talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy , 2002, FEBS letters.

[8]  K. Handa,et al.  Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary note. , 2001, Biochemical and biophysical research communications.

[9]  D. Kingsley,et al.  Analysis of the synthesis, intracellular sorting, and function of glycoproteins using a mammalian cell mutant with reversible glycosylation defects. , 1989, Methods in cell biology.

[10]  W. Isaacs,et al.  Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. , 1996, Cancer research.

[11]  K. Handa,et al.  Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. , 2000, Biochemical and biophysical research communications.

[12]  K. Handa,et al.  A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. , 1997, Biochemical and biophysical research communications.

[13]  S. Levy,et al.  The tetraspanin superfamily: molecular facilitators , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  F. Berditchevski,et al.  Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). , 1996, Journal of immunology.

[15]  F. Gaeta,et al.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. , 1990, Science.

[16]  C. Boucheix,et al.  CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA‐DR and VLA integrins , 1996, European journal of immunology.

[17]  J. Rojo,et al.  Carbohydrate-Carbohydrate Interactions in Biological and Model Systems , 2002 .

[18]  F. Berditchevski,et al.  A Novel Link between Integrins, Transmembrane-4 Superfamily Proteins (CD63 and CD81), and Phosphatidylinositol 4-Kinase* , 1997, The Journal of Biological Chemistry.

[19]  T. Irimura,et al.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. , 1993, Cancer research.

[20]  A. Varki,et al.  Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Barrett,et al.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.

[22]  K. Handa,et al.  Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM. , 2000, Biochemical and biophysical research communications.

[23]  B. Sordat,et al.  Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.

[24]  N. Bovin CARBOHYDRATE-CARBOHYDRATE INTERACTIONS : A REVIEW , 1996 .

[25]  P. Crocker,et al.  Siglecs in the immune system , 2001, Immunology.

[26]  K. Handa,et al.  Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. , 1992, The Journal of biological chemistry.

[27]  K. Handa,et al.  Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. , 1999, Cancer research.

[28]  K. Handa,et al.  Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility* , 2002, The Journal of Biological Chemistry.

[29]  K. Iwabuchi,et al.  Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with Signaling* , 1998, The Journal of Biological Chemistry.

[30]  S. Hakomori Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[31]  T Irimura,et al.  Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. , 1989, Cancer research.

[32]  S. Hirohashi,et al.  Cancer cell morphology at the invasive front and expression of cell adhesion‐related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis , 1996, Cancer.

[33]  S. Hakomori INAUGURAL ARTICLE by a Recently Elected Academy Member:The glycosynapse , 2002 .

[34]  F. Berditchevski,et al.  Generation of Monoclonal Antibodies to Integrin-associated Proteins , 1997, The Journal of Biological Chemistry.

[35]  R. Kannagi Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer , 1997, Glycoconjugate Journal.

[36]  S. Hakomori,et al.  Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.

[37]  D. Azorsa,et al.  Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. , 1999, The Biochemical journal.

[38]  K. Shitara,et al.  Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. , 1987, Cancer research.

[39]  K. Handa,et al.  GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. , 2001, Biochemistry.

[40]  T. Sasaki,et al.  Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. , 1993, The Journal of biological chemistry.

[41]  S. Hakomori,et al.  Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. , 1991, The Journal of biological chemistry.

[42]  K. Handa,et al.  Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression , 2001, FEBS letters.

[43]  K. Iwabuchi,et al.  GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells* , 1998, The Journal of Biological Chemistry.

[44]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[45]  M. Yasutomi,et al.  Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Lex (defined by MAb FH6) and LCP , 1991, Clinical & Experimental Metastasis.